We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

170 hedge funds and large institutions have $1.59B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 64 increasing their positions, 53 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 9

104% more call options, than puts

Call options by funds: $4.15M | Put options by funds: $2.03M

40% more capital invested

Capital invested by funds: $1.13B → $1.59B (+$451M)

21% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 53

18% more funds holding

Funds holding: 144 → 170 (+26)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

Holders
170
Holders Change
+26
Holders Change %
+18.06%
% of All Funds
3.49%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
36
Increased
64
Reduced
53
Closed
9
Calls
$4.15M
Puts
$2.03M
Net Calls
+$2.12M
Net Calls Change
+$2.97M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$25.5M
2
BlackRock
BlackRock
New York
+$18.9M
3
PA
Perceptive Advisors
New York
+$17.2M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$15.6M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$10.2M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$22.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.7M
3
UBS Group
UBS Group
Switzerland
-$17.4M
4
Goldman Sachs
Goldman Sachs
New York
-$14.6M
5
EC
EcoR1 Capital
California
-$13.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
ASRS
126
Arizona State Retirement System
Arizona
$359K +$45.2K +2,100 +17%
Public Employees Retirement Association of Colorado
127
Public Employees Retirement Association of Colorado
Colorado
$350K +$297K +13,778 New
PP
128
Paloma Partners
Connecticut
$346K +$294K +13,625 New
CC
129
Centiva Capital
New York
$345K +$293K +13,596 New
ACM
130
AlphaCrest Capital Management
New York
$343K +$291K +13,500 New
BNP Paribas Financial Markets
131
BNP Paribas Financial Markets
France
$316K -$533K -24,749 -67%
AC
132
Allstate Corporation
Illinois
$306K +$797 +37 +0.3%
JCM
133
JS Capital Management
New York
$300K +$254K +11,800 New
OPERF
134
Oregon Public Employees Retirement Fund
Oregon
$299K -$112K -5,200 -31%
OMC
135
Old Mission Capital
Illinois
$290K +$246K +11,400 New
Handelsbanken Fonder
136
Handelsbanken Fonder
Sweden
$287K +$243K +11,300 New
AB
137
Amalgamated Bank
New York
$264K +$224K +10,399 New
CSS
138
Cubist Systematic Strategies
Connecticut
$263K +$143K +6,632 +178%
BC
139
Birchview Capital
Vermont
$254K – – –
GT
140
Glenmede Trust
Pennsylvania
$230K +$48K +2,230 +33%
Mitsubishi UFJ Asset Management
141
Mitsubishi UFJ Asset Management
Japan
$222K +$30.9K +1,436 +20%
Allianz Asset Management
142
Allianz Asset Management
Germany
$210K -$2.41M -112,008 -93%
MC
143
Moors & Cabot
Massachusetts
$206K +$174K +8,100 New
CA
144
Claro Advisors
Massachusetts
$206K +$175K +8,127 New
AC
145
Alexandria Capital
Virginia
$203K +$172K +8,000 New
AC
146
Athanor Capital
New York
$200K +$170K +7,882 New
Zurich Cantonal Bank
147
Zurich Cantonal Bank
Switzerland
$179K +$55K +2,555 +57%
BAMCO Inc
148
BAMCO Inc
New York
$163K – – –
AIP
149
Ameritas Investment Partners
Nebraska
$146K +$27.8K +1,289 +29%
FMT
150
First Mercantile Trust
Tennessee
$139K +$118K +5,468 New
4 5
6
7 8

DRNA Hedge Fund Activity: Q2 2020 in Review

170 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q2 2020, worth a combined $1.59B — up 40% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new DRNA positions and 9 closed out — a net gain of 27 holders — while 64 added to existing stakes and 53 trimmed.

The largest buyer was State Street, adding an estimated $25.5M. The largest seller was Citadel Advisors, cutting an estimated $22.5M.

  • 170 institutional investors held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q2 2020, up from 144 in Q1 2020.
  • Funds reported $1.59B of Dicerna Pharmaceuticals, Inc. stock for Q2 2020, up 40% quarter-over-quarter.
  • 36 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q2 2020 and 9 closed out, a net change of +27 holders.
  • The largest Dicerna Pharmaceuticals, Inc. buyer in Q2 2020 was State Street, an estimated $25.5M added.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q2 2020 was Citadel Advisors, an estimated $22.5M sold.

Based on aggregated 13F filings for Q2 2020.